The role of cytotoxic chemotherapy in the management of progressive glioblastoma
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The role of cytotoxic chemotherapy in the management of progressive glioblastoma
Authors
Keywords
-
Journal
JOURNAL OF NEURO-ONCOLOGY
Volume 118, Issue 3, Pages 501-555
Publisher
Springer Nature
Online
2014-04-17
DOI
10.1007/s11060-013-1338-5
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Procarbazine, carmustine, and vincristine (PBV) for chemotherapy pre-treated patients with recurrent glioblastoma: a single-institution analysis
- (2012) Jan Kuhnhenn et al. JOURNAL OF NEURO-ONCOLOGY
- Dose dense 1 week on/1 week off temozolomide in recurrent glioma: a retrospective study
- (2012) Walter Taal et al. JOURNAL OF NEURO-ONCOLOGY
- Patupilone (Epothilone B) for Recurrent Glioblastoma: Clinical Outcome and Translational Analysis of a Single-Institution Phase I/II Trial
- (2012) Christoph Oehler et al. ONCOLOGY
- Sagopilone (ZK-EPO, ZK 219477) for recurrent glioblastoma. A phase II multicenter trial by the European Organisation for Research and Treatment of Cancer (EORTC) Brain Tumor Group
- (2011) R. Stupp et al. ANNALS OF ONCOLOGY
- Adult glioblastoma multiforme survival in the temozolomide era: A population-based analysis of Surveillance, Epidemiology, and End Results registries
- (2011) Amy S. Darefsky et al. CANCER
- It Is Time to Include Patients With Brain Tumors in Phase I Trials in Oncology
- (2011) Patrick Y. Wen et al. JOURNAL OF CLINICAL ONCOLOGY
- Salvage therapy with single agent bendamustine for recurrent glioblastoma
- (2011) Marc C. Chamberlain et al. JOURNAL OF NEURO-ONCOLOGY
- Improved survival time trends for glioblastoma using the SEER 17 population-based registries
- (2011) Matthew Koshy et al. JOURNAL OF NEURO-ONCOLOGY
- Phase II trial of low-dose continuous (metronomic) treatment of temozolomide for recurrent glioblastoma
- (2011) D.-S. Kong et al. NEURO-ONCOLOGY
- Regression of Recurrent Malignant Gliomas With Convection-Enhanced Delivery of Topotecan
- (2011) Jeffrey N. Bruce et al. NEUROSURGERY
- Ifosfamide, Carboplatin and Etoposide in Recurrent Malignant Glioma
- (2011) N. Schäfer et al. ONCOLOGY
- Treatment of recurrent glioblastoma with intra-arterial BCNU [1, 3-bis (2-chloroethyl)-1-nitrosourea]
- (2010) Eberval Gadelha Figueiredo et al. ARQUIVOS DE NEURO-PSIQUIATRIA
- BCNU for recurrent glioblastoma multiforme: efficacy, toxicity and prognostic factors
- (2010) Thomas Reithmeier et al. BMC CANCER
- Carboplatin Chemotherapy in Patients with Recurrent High-grade Glioma
- (2010) L.J. Murray et al. CLINICAL ONCOLOGY
- Phase II Trial of Continuous Dose-Intense Temozolomide in Recurrent Malignant Glioma: RESCUE Study
- (2010) James R. Perry et al. JOURNAL OF CLINICAL ONCOLOGY
- Low-dose fotemustine for recurrent malignant glioma: a multicenter phase II study
- (2010) Alessandra Fabi et al. JOURNAL OF NEURO-ONCOLOGY
- Efficacy of protracted dose-dense temozolomide in patients with recurrent high-grade glioma
- (2010) Ufuk Abacioglu et al. JOURNAL OF NEURO-ONCOLOGY
- A new schedule of fotemustine in temozolomide-pretreated patients with relapsing glioblastoma
- (2010) Raffaele Addeo et al. JOURNAL OF NEURO-ONCOLOGY
- Convection-enhanced delivery of nanocarriers for the treatment of brain tumors
- (2009) Emilie Allard et al. BIOMATERIALS
- Treatment of recurrent malignant gliomas with fotemustine monotherapy: impact of dose and correlation with MGMT promoter methylation
- (2009) Alessandra Fabi et al. BMC CANCER
- Fotemustine as second-line treatment for recurrent or progressive glioblastoma after concomitant and/or adjuvant temozolomide: a phase II trial of Gruppo Italiano Cooperativo di Neuro-Oncologia (GICNO)
- (2009) Alba A. Brandes et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Phase II Trial of Gliadel plus O6-Benzylguanine in Adults with Recurrent Glioblastoma Multiforme
- (2009) J. A. Quinn et al. CLINICAL CANCER RESEARCH
- Management of newly diagnosed glioblastoma: guidelines development, value and application
- (2009) Jeffrey J. Olson et al. JOURNAL OF NEURO-ONCOLOGY
- Rechallenge with temozolomide in patients with recurrent gliomas
- (2009) Antje Wick et al. JOURNAL OF NEUROLOGY
- Phase II study of ifosfamide, carboplatin, and etoposide in patients with a first recurrence of glioblastoma multiforme
- (2009) Tomokazu Aoki et al. JOURNAL OF NEUROSURGERY
- Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial
- (2009) Roger Stupp et al. LANCET ONCOLOGY
- Nimustine (ACNU) Plus Teniposide (VM26) in Recurrent Glioblastoma
- (2009) M. Glas et al. ONCOLOGY
- Second-line chemotherapy with fotemustine in temozolomide-pretreated patients with relapsing glioblastoma: a single institution experience
- (2008) Silvia Scoccianti et al. ANTI-CANCER DRUGS
- Multi-institutional phase II study of temozolomide administered twice daily in the treatment of recurrent high-grade gliomas
- (2008) Casilda Balmaceda et al. CANCER
- Temozolomide rechallenge in recurrent malignant glioma by using a continuous temozolomide schedule
- (2008) James R. Perry et al. CANCER
- Guidelines for the treatment of newly diagnosed glioblastoma: introduction
- (2008) Jeffrey J. Olson et al. JOURNAL OF NEURO-ONCOLOGY
- A multi-institutional phase II study on second-line Fotemustine chemotherapy in recurrent glioblastoma
- (2008) Maria Grazia Fabrini et al. JOURNAL OF NEURO-ONCOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started